HOSP Partners are organizations that align with the commitment and advocacy efforts to improve patient outcomes and to innovate patient care through the integrated specialty pharmacy model. These organizations understand the value of collaboration in the advancements in research, advocacy, and education.
To learn more about the HOSP Partners, click on the logo below to preview their profile that provides information on their organization.
At EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany, in the US and Canada, our scientific approach in oncology focuses on oncogenic pathways, immuno-oncology, and DNA damage response. To deliver breakthrough cancer therapies, we complement our internal expertise and development programs with scientific collaborations to improve trial designs, accelerate treatment development, and partner on exciting asset programs and integrated innovations. We aim to deliver personalized treatment options that may potentially transform cancer care.
We’re imagining the future of healthcare for those living with difficult to treat conditions like multiple sclerosis, cancer and infertility.
Company URL: https://www.emdserono.com/us-en